ALPMF - Astellas and Elpiscience collaborate for novel bi-specific macrophage engagers
2023-12-28 04:45:39 ET
More on Astellas Pharma
- FDA approves Keytruda/Padcev combo therapy for bladder cancer
- Biden eyes seizing patents of taxpayer-funded drugs in bid to slash prices
- Seeking Alpha’s Quant Rating on Astellas Pharma ADR
For further details see:
Astellas and Elpiscience collaborate for novel bi-specific macrophage engagers